Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8ae3c8fd8ac89b71d5d64a32bf6524bd http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_139cc188d3fce955442ff4fdcc2fb316 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-606 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-10 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L29-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L29-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-00 |
filingDate |
2004-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1aab1ff7aea2e13a114a33ec60f3f12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80962cfbb90ea2949e5a52ba830408e9 |
publicationDate |
2005-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2005238684-A1 |
titleOfInvention |
Implantable or insertable medical articles having covalently modified, biocompatible surfaces |
abstract |
Implantable or insertable medical devices comprising a surface region that is modified by covalently coupling a molecular species (or a combination of molecular species) to the same. The molecular species are selected such that the resulting modified surface region has critical surface energy between 20 and 30 dynes/cm. In certain embodiments, the covalently coupled molecular species comprise one or more methyl groups. An advantage of the present invention is that novel medical devices are provided, which have a surface with a critical surface energy value that has been shown to display enhanced biocompatibility, including enhanced throboresistance, relative to other surfaces. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007048383-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018228944-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008268013-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3011980-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016062882-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10980923-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007178124-A1 |
priorityDate |
2004-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |